診断用カテーテルの世界市場-2022-2029

市場力学

診断用カテーテルの世界市場の成長は、世界の心臓血管手術の増加、外科手術、低侵襲手術への傾倒などの要因によって推進されています。

斬新で革新的な技術的進歩の増加が市場成長の原動力となっています。

診断用カテーテルに関連する技術的進歩の増加が、世界的に市場の成長を後押ししています。例えば、2021年6月、アボット社は、高度な心不全を適切に治療するための機械的循環支援装置の需要増をサポートできると発表しました。

全米健康栄養調査（NHANES）のデータ（2020年）によると、推定620万人の20歳以上のアメリカ人成人（2.2％）が心不全を患っています。570万人以上のアメリカ人が心不全を患っており、年間約915,000人の新規患者が診断されています。心不全、心血管疾患、冠動脈疾患などの慢性疾患の有病率は、世界的に不健康なライフスタイルや環境の変化により増加しています。これらの最新の製品の発売や技術の進歩は、これらの病気に対抗することができるようになります。例えば、2022年4月、フランクリン・メディカル・マウンテンは、米国食品医薬品局から経皮的カテーテルシステム「UltraNav」の承認を取得したと発表しました。これは、経皮的穿刺による心血管カテーテルの制御されたデリバリーを提供するものです。

主要なキープレイヤーは、新規の革新的な製品を生産しており、市場の成長を導き出すために、これらのキープレイヤーによって様々なパイプラインと研究が行われています。例えば、2022年8月、アストラゼネカは、DAPA-HFおよびDELIVERの第III相試験の分析から、心不全患者におけるプラセボに対するファルキシガの死亡率ベネフィットを示す新規結果を発表しました。

診断用カテーテルに関連する副作用は、市場の成長を阻害します。

しかし、熟練した医療従事者の不足、政府の厳しい規制、副作用の発現が市場の足かせとなります。中でも、副作用の発生は市場を抑制すると予想されます。例えば、脳卒中、化学物質アレルギー、食道損傷などは、全人口に対する割合が少ないです。

COVID-19の影響度分析

コビド19の普及に伴う戸締りや渡航制限により、新規診断用カテーテルメーカーに問題が発生しました。COVID-19感染の拡大は主要な経済に大きな影響を与えたため、診断用カテーテル治療薬の生産は大きな影響を受けた。

市場参加者は、研究市場を活用し、パンデミックに対抗するための最先端のアイテムを作成することによって、長期的および短期的な成長戦略を変えています。COVID-19が診断用カテーテル産業に被害を与えたとしても、事業運営のためのバックアッププランをできるだけ早く準備し、実行することが重要です。

世界の診断用カテーテル市場レポートでは、約40以上の市場データ表、45以上の図、200ページ（概算）にアクセスできると思われます。

目次

第1章 市場調査手法とスコープ

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

• 市場影響要因
  • 促進要因
    • 技術的進歩の増加
    • 革新的な製品の上市の増加
  • 抑制要因
    • 診断用カテーテルに関連する副作用
    • 経験豊富な専門家の不足
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 技術別

• 画像診断
  • 血管造影カテーテル
  • MRIガイドカテーテル
  • 血管内超音波カテーテル（IVUS）
  • 電気生理マッピング（EP）
  • 心拍出量カテーテル
• 非画像診断
  • 圧力モニタリングカテーテル
  • 流量モニタリングカテーテル
  • オキシメトリーカテーテル
  • 温度モニタリングカテーテル
  • クリティカルケアモニタリングシステム

第8章 製品タイプ別

• 固定式カーブカテーテル
• ステアラブルカテーテル
• アドバンストマッピングカテーテル

第9章 アプリケーション別

• 循環器領域
• 消化器内科
• 泌尿器科
• 神経学

第10章 エンドユーザー別

• 病院
• 診断センター
• 専門クリニック
• その他

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第12章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク

第13章 企業プロファイル

• B.Braun Melsungen AG
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Abbott
• Medtronic
• Boston Scientific
• Infiniti Medical
• Merit Medical
• Osypka AG
• Terumo Corporation
• Johnson & Johnson
• Royal Philips

第14章 診断用カテーテルの世界市場-DataM

Market Overview

Diagnostic Catheter Market was valued at US$ 4,292.31 million in 2021 and is estimated to reach US$ 6,628.54 million by 2029, growing at a CAGR of 7.04% during the forecast period (2022-2029).

A diagnostic catheter is a thin plastic tube inserted into the artery through a small incision on the skin. Once the catheter is guided to the area to be examined, a contrast material (radiopaque media or therapeutic agent) is injected through the tube and images or required information are captured using technological equipment such as (micro cameras, x-ray fluids, pressure monitors, etc.).

Market Dynamics

The global diagnostic catheter market growth is driven by factors, such as the increase in cardiovascular surgeries globally, surgical procedures, and an inclination towards minimally invasive surgeries.

The increasing number of novel, innovative technological advancements are driving the market growth.

The market is driven by the increasing technological advancements related to diagnostic catheters fuelling the market's growth globally. For instance, in Jun 2021, Abbott announced that the company could support the growing demand for mechanical circulatory support devices to treat advanced heart failure properly.

According to the National Health and Nutrition Examination Survey (NHANES) data (2020), an estimated 6.2 million American adults ≥20 years of age (2.2%) had heart failure. More than 5.7 million Americans suffer from heart failure, and approximately 915,000 new patients are diagnosed annually. The prevalence of chronic ailments like heart failure, cardiovascular disease, and coronary artery disease is increasing due to unhealthy lifestyles and changing environments worldwide. These latest product launches and technological advances will be able to combat these diseases. For instance, In Apr 2022, Franklin Medical Mountain announced it received approval for UltraNav, a transseptal catheter system, from the United States Food and Drug Administration. It will provide controlled delivery of cardiovascular catheters by the transseptal puncture.

Major key players are producing novel, innovative products and various pipelines and studies are being conducted by these key players to derive market growth. For instance, in Aug 2022, AstraZeneca presented its novel results from the analysis of phase III trials of DAPA-HF and DELIVER that shows the mortality benefit of Farxiga over placebo in heart failure patients.

The side effects associated with diagnostic catheters will hamper the market's growth.

However, the lack of skilled medical professionals, stringent government regulations, and the onset of side effects hamper the market. Among these, the onset of side effects is expected to restrain the market. For instance, stroke, chemical allergies, and esophageal injury are seen in less percentage of the total population.

COVID-19 Impact Analysis

Due to lockdowns and travel restrictions brought on by the spread of COVID-19, makers of novel diagnostic catheters experienced problems. Because the spread of COVID-19 infections badly impacted major economies, diagnostic catheter therapeutics production was greatly impacted.

Market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Even though COVID-19 harmed the diagnostic catheter industry, preparing and implementing backup plans as soon as possible for business operations is crucial.

Segment Analysis

The imaging diagnostic catheters segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The imaging diagnostic has the largest market share in the forecast period. Electrophysiology mapping (EP) devices sub segment hold the largest market share as these catheter devices are often used to confirm the atrial fibrillation diagnosis and to decide its most suitable treatment. Due to its incorporated mapping capability, the usage of EP mapping catheters is increasing. The non-mapping electrophysiology catheters are less expensive than mapping ones as they do not provide the mapping. Various latest innovations are leading towards the growth of the market. For instance, in Jan 2022, Abbott announced that its cardiac mapping platform, Ensite X EP system with Omnipolar technology, got clearance from the U.S. FDA. This mapping system is developed to assist physicians in better treatment of cardiac arrhythmias. It provides the heart's detailed three-dimensional map as it's designed with the electrophysiologist's inputs.

Geographical Analysis

The North American region holds the largest global diagnostic catheter market.

North America dominates the diagnostic catheter market and is expected to show a similar trend over the forecast period. The growth of North American diagnostic catheters can be attributed to the rising prevalence of heart failure cases and the surge in the geriatric population. Strong healthcare infrastructure and an increase in research and development expenditure are to blame for this supremacy. Furthermore, the rising prevalence of cardiovascular diseases in this region due to unhealthy lifestyles and diets has propelled diagnostic catheter demand in the market.

According to the American Heart Association report 2020, approximately 790,000 people in the U.S. have heart attacks yearly. The rising number of people suffering from cardiovascular diseases and growing technological advancements and mergers or acquisitions by key players boost the demand for diagnostic catheter treatment in this region. For instance, in Jun 2021, Abiomed announced its acquisition of a precardiac catheter developer that provides less invasive options for treating patients with acute decompensated heart failure.

Competitive Landscape

The diagnostic catheter market is highly competitive with local and global companies. Some key players contributing to the market's growth are B. Braun Melsungen AG, Abbott, Medtronic, Boston Scientific, Infiniti Medical, Merit Medical, Osypka AG, Terumo Corporation, and Royal Philips, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the diagnostic catheter market globally. For instance, in Feb 2022, Interrad Medical, a private company of medical devices, and Eloquest Healthcare announced their strategic partnership to expand SecurAcath sales in the U.S.

B. Braun Melsungen AG.

Overview:

B. Braun is a company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and established in 1839. They provide services in around 60 countries and employ around 63,000 people. They have around 5,000 varieties of healthcare products.

Product Portfolio:

Angiodyn diagnostic catheters: Angiodyn diagnostic catheters are used for coronary angiographies. For 1:1 force transmission, it contains a symmetrical braided shaft.

Key Development:

In Jul 2022, B. Braun Medical Inc., a developer of infusion therapy, launched its one-time blood control Introcan safety 2 IV catheter. It is developed for safe IV access.

The global diagnostic catheter market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing novel technological advancements
    • 4.1.1.2. Growing innovative product launches
  • 4.1.2. Restraints:
    • 4.1.2.1. The side effects associated with these diagnostic catheters
    • 4.1.2.2. Unavailability of experienced professional
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Imaging *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.2.3. Angiography catheters
  • 7.2.4. MRI-guided catheters
  • 7.2.5. Intravascular ultrasonic catheters (IVUS)
  • 7.2.6. Electrophysiology mapping (EP)
  • 7.2.7. Cardiac output catheters
• 7.3. Non-Imaging
  • 7.3.1. Pressure monitoring catheters
  • 7.3.2. Flow monitoring catheters
  • 7.3.3. Oximetry catheters
  • 7.3.4. Temperature monitoring catheters
  • 7.3.5. Critical care monitoring systems

8. By Product Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.1.2. Market Attractiveness Index, By Product Type
• 8.2. Fixed curve Catheters *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Steerable Catheters
• 8.4. Advanced mapping Catheters

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Cardiology*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Gastroenterology
• 9.4. Urology
• 9.5. Neurology

10. By End-User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.1.2. Market Attractiveness Index, By End-User
• 10.2. Hospital*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Diagnostic Centers
• 10.4. Specialty Clinics
• 10.5. Other

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. The U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. The U.K.
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

• 12.1. Key Developments and Strategies
• 12.2. Company Share Analysis
• 12.3. Product Benchmarking

13. Company Profiles

• 13.1. B.Braun Melsungen AG*
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Key Highlights
  • 13.1.4. Financial Overview
• 13.2. Abbott
• 13.3. Medtronic
• 13.4. Boston Scientific
• 13.5. Infiniti Medical
• 13.6. Merit Medical
• 13.7. Osypka AG
• 13.8. Terumo Corporation
• 13.9. Johnson & Johnson
• 13.10. Royal Philips

LIST NOT EXHAUSTIVE

14. Global Diagnostic Catheter Market - DataM

• 14.1. Appendix
• 14.2. About Us and Services
• 14.3. Contact Us